Medicine and Health Sciences Commons^™

Association Between Regional Distributions Of Sars-Cov-2 Seroconversion And Out-Of-Hospital Sudden Death During The First Epidemic Outbreak In New York., K. M. Coleman, M. Saleh, S. E. Mountantonakis

Journal Articles

Background

Increased incidence of out-of-hospital sudden death (OHSD) has been reported during the coronavirus 2019 (COVID-19) pandemic. New York City (NYC) represents a unique opportunity to examine the epidemiologic association between the two given the variable regional distribution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in its highly diverse neighborhoods.

Objective

The purpose of this study was to examine the association between OHSD and SARS-CoV-2 epidemiologic burden during the first COVID-19 pandemic across the highly diverse neighborhoods of NYC.

Methods

The incidences of OHSD between March 20 and April 22, 2019, and between March 20 and April 22, 2020, …

Outcomes In Patients With Covid-19 Disease And High Oxygen Requirements., G. Rojas-Marte, A. T. Hashmi, M. Khalid, N. Chukwuka, J. Fogel, A. Munoz-Martinez, S. Ehrlich, M. Akbar Waheed, D. Sharma, J. Shani, +6 Additional Authors

Journal Articles

Background

Approximately 19% of people infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) progress to severe or critical stages of the coronavirus disease 2019 (COVID-19) with a mortality rate exceeding 50%. We aimed to examine the characteristics, mortality rates, intubation rate, and length of stay (LOS) of patients hospitalized with COVID-19 disease with high oxygen requirements (critically ill).

Methods

We conducted a retrospective analysis in a single center in Brooklyn, New York. Adult hospitalized patients with confirmed COVID-19 disease and high oxygen requirements were included. We performed multivariate logistic regression analyses for statistically significant variables to reduce any …

Commentary: Covid 19: Don't Throw Caution To The Wind Nor Air Leak. Use Ppe!, R. S. Lazzaro, M. L. Inra, B. Patton

Journal Articles

No abstract provided.

Atrial Fibrillation Is An Independent Predictor For In-Hospital Mortality In Patients Admitted With Sars-Cov-2 Infection., S. E. Mountantonakis, M. Saleh, J. Fishbein, A. Gandomi, M. Lesser, J. Chelico, J. Gabriels, M. Qiu, L. M. Epstein, Northwell Covid-19 Research Consortium

Journal Articles

Background

Atrial fibrillation (AF) is the most encountered arrhythmia and has been associated with worse in-hospital outcomes.

Objective

This study was to determine the incidence of AF in patients hospitalized with coronavirus disease 2019 (COVID-19) as well as its impact on in-hospital mortality.

Methods

Patients hospitalized with a positive COVID-19 polymerase chain reaction test between March 1 and April 27, 2020, were identified from the common medical record system of 13 Northwell Health hospitals. Natural language processing search algorithms were used to identify and classify AF. Patients were classified as having AF or not. AF was further classified as new-onset …

Should Covid-19 Patients > 75 Years Be Ventilated? An Outcome Study., H. Raheja, N. Chukwuka, C. Agarwal, D. Sharma, A. Munoz-Martinez, J. Fogel, M. Khalid, A. T. Hashmi, S. Ehrlich, G. R. Rojas-Marte, +11 Additional Authors

Journal Articles

Background

Elderly patients with COVID-19 disease are at increased risk for adverse outcomes. Current data regarding disease characteristics and outcomes in this population is limited.

Aim

To delineate the adverse factors associated with outcomes of COVID- 19 patients ≥75 years of age.

Design

Retrospective cohort study.

Methods

Patients were classified into mild/moderate, severe/very severe, and critical disease (intubated) based on oxygen requirements. The primary outcome was in-hospital mortality.

Results

355 patients aged ≥75 years hospitalized with COVID-19 between March 19th and April 25th, 2020 were included. Mean age was 84.3 years. One-third of the patients developed critical disease. Mean length …

Mitral Valve-In-Valve And Valve-In-Ring: Tips, Tricks, And Outcomes, L Pirelli, E Hong, R Steffen, T P. Vahl, S K. Kodali, V Bapat

Journal Articles

No abstract provided.

Reduction In St-Segment Elevation Cardiac Catheterization Laboratory Activations In The United States During Covid-19 Pandemic, S Garcia, Ms Albaghdadi, Pm Meraj, C Schmidt, R Garberich, Fa Jaffer, S Dixon, Jj Rade, M Tannenbaum, Td Henry, +2 Additional Authors

Journal Articles

No abstract provided.

Management Of Elective Aortic Valve Replacement Over The Long Term In The Era Of Covid-19, C Basman, Ca Kliger, L Pirelli, Sj Scheinerman

Journal Articles

No abstract provided.

Covid-19 Leading To Acute Encephalopathy In A Patient With Heart Transplant., K Jang, A Khatri, Dt Majure

Journal Articles

No abstract provided.

Guidance For Rebooting Electrophysiology Through The Covid-19 Pandemic From The Heart Rhythm Society And The American Heart Association Electrocardiography And Arrhythmias Committee Of The Council On Clinical Cardiology., Dr Lakkireddy, Mk Chung, Tf Deering, R Gopinathannair, Cm Albert, Lm Epstein, Cv Harding, Jl Hurwitz, Cc Jeffery, Mj Shah, +9 Additional Authors

Journal Articles

No abstract provided.

Effect Of Chloroquine, Hydroxychloroquine, And Azithromycin On The Corrected Qt Interval In Patients With Sars-Cov-2 Infection, M Saleh, J Gabriels, D Chang, Bs Kim, A Mansoor, E Mahmood, P Makker, H Ismail, B Goldner, J Willner, S Beldner, R Mitra, R John, J Chinitz, N Skipitaris, S Mountantonakis, Lm Epstein

Journal Articles

No abstract provided.

Covid-19 In Recent Heart Transplant Recipients: Clinicopathologic Features And Early Outcomes, B. Lima, G. Gibson, S Vullaganti, K. Malhame, S Maybaum, St Hussain, S Shah, Dt Majure, F Wallach, K Jang, V Bijol, Mj Esposito, Ak Williamson, Rm Thomas, Ta Bhuiya, Ha Fernandez, Gr Stevens

Journal Articles

No abstract provided.

Hypermetabolism And Coronavirus Disease 2019, Pj Yu, H Cassiere, S Derosa, K Bocchieri, S Yar, A Hartman

Journal Articles

No abstract provided.

Incidence Of Arrhythmias And Electrocardiographic Abnormalities In Symptomatic Pediatric Patients With Pcr-Positive Sars-Cov-2 Infection, Including Drug-Induced Changes In The Corrected Qt Interval, S Samuel, Ra Friedman, C Sharma, M Ganigara, E Mitchell, C Schleien, Ad Blaufox

Journal Articles

No abstract provided.

Management Of Acute Myocardial Infarction During The Covid-19 Pandemic., E Mahmud, Hl Dauerman, Fg Welt, Jc Messenger, Sv Rao, C Grines, A Mattu, R Jauhar, P Meraj, Td Henry, +3 Additional Authors

Journal Articles

No abstract provided.

Life Interrupted: On The Front Lines With Covid-19, E Argulian, Jw Weinsaft, Rc Hendel, Vp Garg, J Kim, Lm Phillips, J H. Mieres, A Abidov, R Blankstein, J Narula, +1 Additional Author

Journal Articles

No abstract provided.

North American Covid-19 St-Segment-Elevation Myocardial Infarction (Nacmi) Registry: Rationale, Design, And Implications: Rationale And Design Of Nacmi Registry, P Dehghani, Lj Davidson, Cl Grines, K Nayak, J Saw, P Kaul, A Bagai, R Garberich, P Meraj, Td Henry, +9 Additional Authors

Journal Articles

No abstract provided.

Spontaneous Coronavirus Disease 2019 (Covid-19)-Associated Luminal Aortic Thrombus, C Mullan, C Powierza, Pe Miller, A Geirsson, P Vallabhajosyula, R Assi

Journal Articles

No abstract provided.

Aortic Arch Thrombus And Pulmonary Embolism In A Covid-19 Patient, P. Gandotra, A. Supariwala, S. Selim, G. Garra, L. Gruberg

Journal Articles

© 2020 Elsevier Inc. Background: Coronavirus disease 2019 (COVID-19) is associated with endothelial inflammation and a hypercoagulable state resulting in both venous and arterial thromboembolic complications. We present a case of COVID-19-associated aortic thrombus in an otherwise healthy patient. Case Report: A 53-year-old woman with no past medical history presented with a 10-day history of dyspnea, fever, and cough. Her pulse oximetry on room air was 84%. She tested positive for severe acute respiratory syndrome coronavirus 2 infection, and chest radiography revealed moderate patchy bilateral airspace opacities. Serology markers for cytokine storm were significantly elevated, with a serum D-dimer level …

Bradyarrhythmias In Patients With Covid-19: Marker Of Poor Prognosis?, J. S. Chinitz, R. Goyal, M. Harding, G. Veseli, L. Gruberg, R. Jadonath, P. Maccaro, P. Gandotra, L. Ong, L. M. Epstein

Journal Articles

No abstract provided.

Cardiac Catheterization Laboratory Volume Changes During Covid-19—Findings From A Cardiovascular Fellows Consortium, S. Kadavath, J. Mohan, S. Ashraf, A. Kassier, D. Hawwass, N. Madan, N. Salehi, M. Bernardo, M. C. Kim, M. C. Alraies, +13 Additional Authors

Journal Articles

No abstract provided.

Guidance For Rebooting Electrophysiology Through The Covid-19 Pandemic From The Heart Rhythm Society And The American Heart Association Electrocardiography And Arrhythmias Committee Of The Council On Clinical Cardiology: Endorsed By The American College Of Cardiology, D. R. Lakkireddy, M. K. Chung, T. F. Deering, R. Gopinathannair, C. M. Albert, L. M. Epstein, C. V. Harding, J. L. Hurwitz, C. C. Jeffery, A. M. Russo, +9 Additional Authors

Journal Articles

© 2020 The Heart Rhythm Society, the American Heart Association, Inc., and the American College of Cardiology Foundation Coronavirus disease 2019 (COVID-19) has presented substantial challenges to patient care and impacted health care delivery, including cardiac electrophysiology practice throughout the globe. Based upon the undetermined course and regional variability of the pandemic, there is uncertainty as to how and when to resume and deliver electrophysiology services for arrhythmia patients. This joint document from representatives of the Heart Rhythm Society, American Heart Association, and American College of Cardiology seeks to provide guidance for clinicians and institutions reestablishing safe electrophysiological care. To …

Institutional Preparedness Strategies For Heart Failure, Durable Left Ventricular Assist Device, And Heart Transplant Patients During The Coronavirus Disease 2019 (Covid-19) Pandemic, A. Bansal, D. Goldstein, S. Schettle, S. Pepitone, B. Lima, D. T. Pham, J. Cowger, A. Schubert, S. P. Pinney

Journal Articles

No abstract provided.

Outcomes In Patients With Severe Covid-19 Disease Treated With Tocilizumab: A Case-Controlled Study, G. Rojas-Marte, M. Khalid, O. Mukhtar, A. T. Hashmi, M. A. Waheed, S. Ehrlich, A. Aslam, S. Siddiqui, C. Agarwal, J. Shani, +8 Additional Authors

Journal Articles

© The Author(s) 2020. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For permissions, please email: journals.permissions@oup.com. BACKGROUND: COVID-19 is an ongoing threat to society. Patients who develop the most severe forms of the disease have high mortality. The interleukin-6 inhibitor tocilizumab has the potential to improve outcomes in these patients by preventing the development of cytokine release storm. AIMS: To evaluate the outcomes of patients with severe COVID-19 disease treated with the interleukin-6 inhibitor tocilizumab. METHODS: We conducted a retrospective, case-control, single-center study in patients with severe to critical COVID-19 disease treated …

Response: From Cardiology To Covid The Impact Of A Pandemic On Fellowship Training, J. T. Kuvin

Journal Articles

No abstract provided.

Use Of A Smartwatch For Assessment Of The Qt Interval In Outpatients With Coronavirus Disease 2019., J. S. Chinitz, R. Goyal, D. C. Morales, M. Harding, S. Selim, L. M. Epstein

Journal Articles

The coronavirus disease 2019 (COVID-19) pandemic has necessitated rapid implementation of innovative strategies to manage patients remotely to help reduce the risk of community and nosocomial transmission. This case demonstrates the use of an Apple Watch (Apple, Cupertino, CA, USA) to monitor for arrhythmias and QT prolongation in a patient with COVID-19 during home isolation.

Usefulness Of Elevated Troponin To Predict Death In Patients With Covid-19 And Myocardial Injury., D. T. Majure, L. Gruberg, S. G. Saba, C. Kvasnovsky, J. S. Hirsch, R. Jauhar, Northwell Health Covid-19 Research Consortium

Journal Articles

Elevations in troponin levels have been shown to predict mortality in patients with coronavirus disease 2019 (COVID-19). The role of inflammation in myocardial injury remains unclear. We sought to determine the association of elevated troponin with mortality in a large, ethnically diverse population of patients hospitalized with COVID-19, and to determine the association of elevated inflammatory markers with increased troponin levels. We reviewed all patients admitted at our health system with COVID-19 from March 1 to April 27, 2020, who had a troponin assessment within 48 hours of admission. We used logistic regression to calculate odds ratios (ORs) for mortality …

We May Develop Medications Effective Against Covid-19, But Can We Distribute Them Equitably?, D. J. Kersten, A. N. Makaryus

Journal Articles

No abstract provided.

Impact Of Covid-19 Pandemic On Stemi Care: An Expanded Analysis From The United States., S. Garcia, L. Stanberry, C. Schmidt, S. Sharkey, M. Megaly, M. S. Albaghdadi, P. M. Meraj, R. Garberich, H. Khalili, T. D. Henry, +20 Additional Authors

Journal Articles

OBJECTIVE: To evaluate the impact of COVID-19 pandemic migitation measures on of ST-elevation myocardial infarction (STEMI) care.

BACKGROUND: We previously reported a 38% decline in cardiac catheterization activations during the early phase of the COVID-19 pandemic mitigation measures. This study extends our early observations using a larger sample of STEMI programs representative of different US regions with the inclusion of more contemporary data.

METHODS: Data from 18 hospitals or healthcare systems in the US from January 2019 to April 2020 were collecting including number activations for STEMI, the number of activations leading to angiography and primary percutaneous coronary intervention (PPCI), …

Management Of Covid-19 Myopericarditis With Reversal Of Cardiac Dysfunction After Blunting Of Cytokine Storm: A Case Report., A. Li, Y. Garcia-Bengochea, R. Stechel, B. M. Azari

Journal Articles

Background:Coronavirus disease 2019 (COVID-19) is a syndrome that has been associated with multiple cardiac complications including myopericarditis. The pathophysiology and treatment for myopericarditis in the setting of COVID-19 infection is still under investigation. Case summary:We present a case of a 60-year-old male admitted for dyspnoea due to COVID-19. He developed new ST-segment elevation, elevated cardiac enzymes, severe left ventricular dysfunction, and high inflammatory markers in the setting of haemodynamic and respiratory collapse from the viral illness. He was diagnosed with COVID-19-induced myopericarditis. He showed rapid clinical improvement with a rapid wean off pressure support, resolution of electrocardiogram (ECG) findings, and …